SS INNOVATIONS INTERNATIONAL, INC. (SSII) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$2.27M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$3.64M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$1.84M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $97.01K; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$2.27M | (m) | (m) | (m) | (m) | -$4.23M* | (m) | $2.40M | $4.45M | $505.28K |
| 2026-03-31 | Reported | (m) | -$3.64M | (m) | (m) | (m) | $54.19K | -$2.31M | (m) | $995.44K | $4.50M | $151.35K |
| 2025-09-30 | Reported | (m) | -$1.84M | (m) | (m) | (m) | $755.08K* | -$7.47M* | (m) | $786.32K | $4.82M | $1.85M |
| 2025-06-30 | Reported | (m) | $97.01K | (m) | (m) | (m) | $316.65K* | -$3.45M* | (m) | $498.60K | $3.43M | $353.73K |
| 2025-03-31 | Reported | (m) | -$5.92M | (m) | (m) | (m) | $872.80K | -$6.10M | (m) | $1.01M | $3.41M | (m) |
| 2024-09-30 | Reported | (m) | -$3.20M | (m) | (m) | (m) | -$1.70M* | -$2.55M* | (m) | $442.84K | $2.51M | (m) |
| 2024-06-30 | Reported | (m) | -$4.10M | (m) | (m) | (m) | $2.11M* | -$1.02M* | (m) | $759.00K | $2.24M | (m) |
| 2024-03-31 | Reported | (m) | -$9.83M | (m) | (m) | (m) | $127.25K | -$2.67M | (m) | $527.99K | $2.84M | (m) |
| 2023-09-30 | Reported | (m) | -$1.85M | (m) | (m) | (m) | $220.54K* | -$5.59M* | (m) | $291.91K | $1.80M | (m) |
| 2023-06-30 | Reported | (m) | -$5.19M | (m) | $1.89M | (m) | $33.66K* | -$2.89M* | (m) | $246.43K | $5.67M | (m) |
| 2023-03-31 | Reported | (m) | -$1.07M | (m) | (m) | (m) | $71.88K | -$2.48M | (m) | $242.13K | $873.86K | (m) |
| 2022-09-30 | Reported | (m) | -$425.40K | (m) | (m) | (m) | (m) | -$1.98M* | (m) | $156.49K | $484.78K | (m) |
| 2022-06-30 | Reported | (m) | -$725.05K | (m) | (m) | (m) | (m) | -$1.12M* | (m) | $337.41K | $364.35K | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$8.19M | (m) | (m) | (m) | $3.66M | -$18.54M | (m) | $3.69M | $14.85M | $3.97M |
| 2024-12-31 | Reported | (m) | -$18.98M | (m) | (m) | (m) | $661.48K | -$9.50M | (m) | $2.49M | $10.16M | (m) |
| 2023-12-31 | Reported | (m) | -$20.27M | (m) | $5.88M | (m) | $453.33K | -$15.36M | (m) | $1.06M | $10.06M | (m) |
| 2022-12-31 | Reported | (m) | -$2.96M | (m) | $1.44M | (m) | $220.32K | -$5.99M | (m) | $987.44K | $1.94M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |